Navigation Links
International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
Date:8/10/2011

IRVINE, California and AMSTERDAM, August 10, 2011 /PRNewswire/ --

Agendia, a commercial-stage molecular cancer diagnostics company, today announced that the 12th St. Gallen International Breast Cancer Conference (2011) Expert Panel's recommendations highlight the value of molecular subtyping - classifying patients by the particular biological subtype of their tumor - in guiding treatment decisions for breast cancer patients. According to the panel, "it is no longer tenable to consider breast cancer as a single disease" and clinicians "should consider cases within the various distinct subtypes in order to properly assess the relevant evidence and arrive at appropriate therapeutic advice." The panel's updated guidelines, which are released on a semiannual basis, appear in the August 2011 issue of Annals of Oncology in an article titled "Expert Consensus on the Primary Therapy of Early Breast Cancer 2011" by Goldhirsch, et al (Annals of Oncology 22: 1736-1747, 2011).

The panel's recommendations support the clinical value of Agendia's BluePrint assay, which, in combination with the company's FDA-cleared MammaPrint® recurrence test, can accurately classify all patients as Basal, Luminal-A, Luminal-B, or ERBB2 (HER2) and help determine appropriate treatment. Both clinically available, MammaPrint and BluePrint are two components of Agendia's Symphony™ suite of breast cancer treatment products, a comprehensive collection of genetic assays that help address complex treatment decisions for any type and stage of breast cancer.

The panel also recognized that MammaPrint provided such accurate prognoses that patients and physicians may decide that chemotherapy is not required. MammaPrint identifies patients' risk of metastasis, placing them into one of just two groups, high risk and low risk. Women in the low risk group are able to be treated effectively and safely without undergoing chemotherapy and its side effects.

"These r
'/>"/>

SOURCE Agendia B.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
2. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011
3. Millennium Surgical Provides Services and Support to CURE Internationals Zambian Surgical Program
4. HUYA Bioscience International and Shanghai Jiao Tong University Kings Lab Form Alliance
5. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
6. HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010
7. VWR International, LLC to Acquire LabPartner (Shanghai) Co., Ltd.
8. Lightwave Logic Addresses the Bio-Medical Diagnostic Market through an Agreement with FiberLogix International Ltd.
9. FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International
10. FDA, International Counterparts Report Progress on Drug Inspection Collaboration
11. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... England and PISCATAWAY, New ... The Cambridge Crystallographic Data Centre (CCDC) ... (CSD) with a Scientific Symposium and the launch ... provides full web-based access (WebCSD) to the world,s ... 3D searching, new advanced visualisations, intermolecular interaction analysis, ...
(Date:6/30/2015)... , July 1, 2015 Ansell, ... announce the winners of the first Ansell Cares ® ... Room (O.R.) Nurses. The 2015 award, organised in partnership ... perioperative nurses who display exceptional skill and quality in ... education and development. Award ceremonies are taking place today ...
(Date:6/30/2015)... Nortek Security & Control LLC, a ... a leader in the residential and commercial security ... mobile personal emergency response system (mPERS) and telehealth ... Headquartered in Seattle ... products and cloud-based software platforms that enable providers ...
Breaking Medicine Technology:Scientific Symposium and New Software for Crystallographers and Scientists Worldwide to Celebrate 50 Years of the Cambridge Structural Database 2Scientific Symposium and New Software for Crystallographers and Scientists Worldwide to Celebrate 50 Years of the Cambridge Structural Database 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... The World Health Organization (WHO) has granted prequalification ... active immunization of infants and children from 6 weeks ... and otitis media caused by the 13 pneumococcal serotypes ... 18C, 19A, 19F and 23F) contained in the vaccine. ...
... 23 /PRNewswire-FirstCall/ -- Today at the ... Medical Systems U.S.A., Inc. announced that it has ... flat panel detector.  As U.S. installations of the ... will begin benefiting from the seamless transition to ...
Cached Medicine Technology:World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 2World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 3World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 4World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 5World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 6World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 7FUJIFILM's FDR D-EVO™ is Now Available and Shipping 2
(Date:7/1/2015)... ... 2015 , ... Amada Senior Care, premier provider of non-medical in-home care and ... – their Mesa, Arizona location . Amada franchise partners Kris Patmos and Kimberly ... rights to the area after years of experience in the sales and healthcare industries. ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the ... lead a national chief nursing officer recruitment for Capital Health ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., has ... proven record of leading organization-wide compliance adaptation efforts and growing a focus on ...
(Date:7/1/2015)... ... July 01, 2015 , ... Research published in the journal ... app to test eyesight was just as accurate as those from standard paper-based charts ... Tropical Medicine is responsible for the development of the test, which does not depend ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased ... weighing pans, ML-T balances give operators the room they need to carry out ... estate makes ML-T balances a perfect choice for day-to-day weighing in nearly any ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2
... who suffer from asthma, particularly women, may have an ... of 30 years, researchers studied almost 100,000 patients who ... the patients showed any signs of cancer at their ... year after asthma diagnosis until the last day of ...
... is no cure for stiff-person syndrome, a disease marked ... (GAD65), an enzyme involved in the production of a ... which is only mildly successful at controlling symptoms. While ... suspected that it may be an autoimmune disorder. ...
... derived a new gel to reduce the hair loss ... side effects of the treatment of cancer. The pharmaceutical ... contains a drug known as GW8510, helped to prevent ... researcher Stephen Davis said the gel completely prevented hair ...
... take hormone replacement therapy appear to restore their cognitive ... hormone replacement therapy (HRT) can protect against dementia// is ... failed to demonstrate benefit.A new report, from researchers, ... of over 1,000 women from different countries for a ...
... probably get more benefit from investing in gymnasium membership and ... researchers at the Cleavland University // it is better to ... a machine Exercise machines are often advertised in a misleading ... fit to your body, and you may need to learn ...
... recent study has found that early puberty and late menopause ... a common symptom of osteoporosis, or brittle bone disease.// Most ... can occur as a result. , ,Researchers in Norway ... as age when her periods start, age when she first ...
Cached Medicine News:
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
3.5 mm blade. Round handle. Designated most popular model or size....
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
Medicine Products: